Page last updated: 2024-10-31

molsidomine and Liver Dysfunction

molsidomine has been researched along with Liver Dysfunction in 2 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"Molsidomine is a prodrug for the formation of nitric oxide (NO)."1.29Clinical pharmacokinetics of molsidomine. ( Parnham, MJ; Rosenkranz, B; Winkelmann, BR, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenkranz, B1
Winkelmann, BR1
Parnham, MJ1
Huber, T1
Grosse-Heitmeyer, W1
Rietbrock, S1
Harder, S1

Other Studies

2 other studies available for molsidomine and Liver Dysfunction

ArticleYear
Clinical pharmacokinetics of molsidomine.
    Clinical pharmacokinetics, 1996, Volume: 30, Issue:5

    Topics: Absorption; Administration, Oral; Age Factors; Angina Pectoris; Coronary Disease; Humans; Injections

1996
Pharmacokinetics and pharmacodynamics of molsidomine in patients with liver dysfunction due to congestive heart failure.
    International journal of clinical pharmacology, therapy, and toxicology, 1992, Volume: 30, Issue:11

    Topics: Adult; Aged; Biological Availability; Biotransformation; Central Venous Pressure; Female; Half-Life;

1992
chemdatabank.com